JPI-547
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for JPI-547, covering 2024-08-27 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer [Phase 1, Phase 2]